Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas-Reference-Cited by-同舟云学术

Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas

Published:2011-11-01 Issue:13 Volume:118 Page:3330-3336
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Italiano Antoine,Cioffi Angela,Penel Nicolas,Levra Matteo Giaj,Delcambre Corinne,Kalbacher Elsa,Chevreau Christine,Bertucci François,Isambert Nicolas,Blay Jean-Yves,Bui Binh,Antonescu Cristina,D'Adamo David R.,Maki Robert G.,Keohan Mary Louise

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26599/fullpdf

Reference41 articles.

1. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases;Fayette;Ann Oncol.,2007

2. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma;Bramwell;Cochrane Database Syst Rev.,2003

3. Molecularly targeted treatment for dermatofibrosarcoma protuberans;McArthur;Semin Oncol.,2004

4. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials;Rutkowski;J Clin Oncol.,2010

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The challenge of running trials in advanced angiosarcoma: A systematic review of the literature from EORTC/STBSG to guide the development of angiosarcoma-specific trials;European Journal of Cancer;2024-08

2. Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group;Cancer Treatment Reviews;2024-05

3. An Update on Cutaneous Angiosarcoma Diagnosis and Treatment;Cutis;2024-05-01

4. Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma;Biomedicine & Pharmacotherapy;2024-04

5. Competing-risks model for predicting the prognosis of patients with angiosarcoma based on the SEER database of 3905 cases;Holistic Integrative Oncology;2024-03-15